WAG
BIIB icon

Wilkerson Advisory Group’s Biogen BIIB Stock Holding History

Wilkerson Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
672
+79
+13% +$15.1K 0.04% 127
2026
Q1 		$109K Buy
593
+334
+129% +$61.5K 0.04% 134
2025
Q4 		$45.6K Buy
+259
New +$42.3K 0.02% 170

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wilkerson Advisory Group's BIIB Position: Q2 2026 in Review

Wilkerson Advisory Group increased its Biogen (BIIB) stake by 13% in Q2 2026, buying an estimated $15.1K and bringing the position to 672 shares worth $145K. The position accounts for 0.04% of the portfolio, ranked #127.

Wilkerson Advisory Group first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Wilkerson Advisory Group held 672 shares of Biogen worth $145K as of Q2 2026.
  • Wilkerson Advisory Group bought 79 Biogen shares in Q2 2026, an estimated $15.1K.
  • Biogen made up 0.04% of Wilkerson Advisory Group's portfolio in Q2 2026, its #127 holding.
  • Wilkerson Advisory Group first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.